80 related articles for article (PubMed ID: 16061983)
21. Recombinant vesicular stomatitis viruses encoding simian immunodeficiency virus receptors target infected cells and control infection.
Okuma K; Boritz E; Walker J; Sarkar A; Alexander L; Rose JK
Virology; 2006 Mar; 346(1):86-97. PubMed ID: 16325218
[TBL] [Abstract][Full Text] [Related]
22. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies.
Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L
Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies.
Putnak JR; de la Barrera R; Burgess T; Pardo J; Dessy F; Gheysen D; Lobet Y; Green S; Endy TP; Thomas SJ; Eckels KH; Innis BL; Sun W
Am J Trop Med Hyg; 2008 Jul; 79(1):115-22. PubMed ID: 18606774
[TBL] [Abstract][Full Text] [Related]
24. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
[TBL] [Abstract][Full Text] [Related]
25. Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.
Zhan X; Martin LN; Slobod KS; Coleclough C; Lockey TD; Brown SA; Stambas J; Bonsignori M; Sealy RE; Blanchard JL; Hurwitz JL
Vaccine; 2005 Nov; 23(46-47):5306-20. PubMed ID: 16095768
[TBL] [Abstract][Full Text] [Related]
26. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
[TBL] [Abstract][Full Text] [Related]
28. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
[TBL] [Abstract][Full Text] [Related]
29. Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals.
Schuitemaker H; Kootstra NA
Methods Mol Biol; 2005; 304():17-24. PubMed ID: 16061963
[TBL] [Abstract][Full Text] [Related]
30. An immunoperoxidase plaque assay for reticuloendotheliosis virus and its application to a sensitive serum neutralization assay.
Calvert JG; Nazerian K
Avian Dis; 1994; 38(1):165-71. PubMed ID: 8002888
[TBL] [Abstract][Full Text] [Related]
31. Expeditious neutralization assay for human metapneumovirus based on a recombinant virus expressing Renilla luciferase.
Zhou M; Kitagawa Y; Yamaguchi M; Uchiyama C; Itoh M; Gotoh B
J Clin Virol; 2013 Jan; 56(1):31-6. PubMed ID: 23084005
[TBL] [Abstract][Full Text] [Related]
32. Development of a microplate assay for the detection of single plaque-forming units of bacteriophage PhiX174 in crude lysates.
Slattery SD; Valentine CR
Environ Mol Mutagen; 2003; 41(2):121-5. PubMed ID: 12605381
[TBL] [Abstract][Full Text] [Related]
33. [Rabies virus study by the plaque forming system. A simplified technique].
Salaun JJ
Ann Biol Clin (Paris); 1978; 36(1):23-5. PubMed ID: 686516
[TBL] [Abstract][Full Text] [Related]
34. Virus quantification by immunofluorescence of cells grown in agar.
Tjøtta E; Hungnes O; Grinde B
Dev Biol Stand; 1990; 72():305-8. PubMed ID: 2282989
[TBL] [Abstract][Full Text] [Related]
35. [Quantitative determination of the infective activity of the human immunodeficiency virus by plaque formation using monolayer cultures].
Nosik MN; Stepanova LG; Matsevich GR
Vopr Virusol; 1995; 40(5):202-5. PubMed ID: 8659172
[TBL] [Abstract][Full Text] [Related]
36. [Comparative studies of two alphavirus by macroplaque assays and by a fluorescent focus method in Vero cell lines (author's transl)].
Tignor GH; Digoutte JP
Ann Microbiol (Paris); 1976 Oct; 127B(3):439-44. PubMed ID: 828464
[TBL] [Abstract][Full Text] [Related]
37. A rapid plaque method using vertical tube cultures for titration of viruses and neutralizing antibodies.
Wallis C; Parks W; Sakurada N; Melnick JL
Bull World Health Organ; 1965; 33(6):795-801. PubMed ID: 5295403
[TBL] [Abstract][Full Text] [Related]
38. Micro-assay systems for infectious laryngotracheitis virus.
Robertson GM; Egerton JR
Avian Dis; 1977; 21(1):133-5. PubMed ID: 190993
[No Abstract] [Full Text] [Related]
39. A method for the detection of virus infectivity in single cells and real time: Towards an automated fluorescence neutralization test.
Maistriau M; Carletti T; Zakaria MK; Braga L; Faoro V; Vasileiadis V; Marcello A
Virus Res; 2017 Jun; 237():1-6. PubMed ID: 28501626
[TBL] [Abstract][Full Text] [Related]
40. Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition.
Sheik-Khalil E; Bray MA; Özkaya Şahin G; Scarlatti G; Jansson M; Carpenter AE; Fenyö EM
BMC Infect Dis; 2014 Aug; 14():472. PubMed ID: 25176034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
